Retroperitoneal soft tissue sarcomas (original) (raw)

Soft tissue sarcomas (STS) represent a rare malignancy, accounting for only 1% of all cancer cases, with retroperitoneal sarcomas being a particularly uncommon occurrence. The challenges in managing retroperitoneal STS arise from anatomical factors, leading to a poor long-term prognosis for patients. This study presents a retrospective analysis of patients who underwent surgical treatment for retroperitoneal STS over a 20-year period, examining long-term outcomes and patterns of failure. The findings indicate that surgery remains the mainstay of treatment; however, the overall survival rates and impact of additional therapies such as radiation or chemotherapy require further investigation.